Congratulations to Progress Corporate Park tenant Banyan Biomarkers, Inc.! Banyan Biomarkers, a biotechnology company, recently secured $6 million in private investments. Banyan Biomarkers is just one of the successful companies that make Progress Corporate Park a vibrant, productive biotechnology park.
By Anthony Clark | The Gainesville Sun
Banyan Biomarkers, with offices in Alachua and Carlsbad, Calif., has secured $6 million in funding from private investors, the company announced Thursday.
The funding will be used for further research and development of a blood test to diagnose traumatic brain injury.
The company was founded in 2002 by researchers at the University of Florida McKnight Brain Institute who discovered proteins from the breakdown of dying brain cells in blood.
Banyan is in the process of enrolling 2,000 patients in a clinical trial funded by a $26.3 million contract with the Department of Defense.
Efforts to reach CEO Jackson Streeter were unsuccessful.
In a February interview, Executive Chairman Hank Nordhoff told the San Diego Union-Tribune that the company was shifting to Carlsbad, Calif., to find employees experienced in diagnostics, but would keep research in Alachua to continue its work with UF.